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access article under the CC BY-NC-NDSummary The gap between orthopaedic basic research and clinical research has been
reduced with the development of modern research technology and the well-accepted concept
of translational medicine. The personnel involved in orthopaedic research realise more clearly
than ever that basic research should be patient centred and clinical-application oriented. The
mainstream of orthopaedic research has been gradually changing from bench-to-bedside to
bedside-to-bench-to-bedside. This paper reviews the history of the Chinese Orthopaedic
Research Society and its future development with a focus on translational medicine in muscu-
loskeletal research and education.
ª 2016 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking
Orthopaedic Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).History of Chinese orthopaedic basic research
Chinese orthopaedic research dates back to ancient times.
Its achievements have made great contributions to the
development of Chinese medicine, especially in the treat-
ment of musculoskeletal injuries, and have gained respect
throughout the world. The book Prescriptions for Fifty-two
Diseases, written around 475 BC, recorded the firstnt of Orthopaedics, Xijing
ersity, 127 Changle Western
06.028
hed by Elsevier (Singapore) Pte Ltd
license (http://creativecommonrealignment of fracture bone using traction splints,
external fixation using small splints, and dynamic traction
splints for intra-articular fractures of phalanges in the
hand. Secrets of Treating Wounds and Bones and Total
Effective Formularies for Emergency of the Tang Dynasty
collected thousands of prescriptions and therapies for bone
injuries. The pharmacologist Shizhen Lee’s Compendium of
Materia Medica of the Ming Dynasty made a careful study of
1892 herbs; of which, 170 can be used in orthopaedic
medicine [1e3]. Nowadays, Chinese orthopaedic re-
searchers are working hard to keep contributing to modern
scientific orthopaedic research combined with traditional
Chinese medicine.on behalf of Chinese Speaking Orthopaedic Society. This is an open
s.org/licenses/by-nc-nd/4.0/).
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Orthopaedic Research Society
In 1980, the Chinese Medical Association organised the
first national meeting of orthopaedics in Tianjing, China,
where it announced the establishment of the Chinese
Orthopaedic Association (COA) [1,2]. Five years later, at
the second national meeting of the COA in 1985, the
Chinese Orthopaedic Research Society (CORS) was foun-
ded with the aim of promoting, supporting, developing,
and encouraging research in clinical orthopaedics,
musculoskeletal diseases, and its related disciplines. In
the past 30 years, CORS has played a leading role in
advancing the integration and transformation of research
resources and achievements nationwide, organising
educational activities and facilitating collaboration among
research groups. As a professional, scientific, and medical
organisation, the importance and impact of CORS extends
increasingly. The board of CORS now consists of over 50
top and leading clinician-scientists and basic scientists
from Mainland China, Hong Kong, Macau, and Taiwan. The
development of CORS may be divided into the following
distinct stages:
Stage I (before 1979)
Before 1979, there was no independent orthopaedic
research organisations in China. In addition, there was a
lack of professional orthopaedic research institutes
including research laboratories and personnel, and aware-
ness of the importance of conducting basic and clinical
research among orthopaedic surgeons.
Stage II (1978e1982)
In 1978, China restarted the enrolment of orthopaedic
postgraduates, which catalysed the development of or-
thopaedic research laboratories, although most of these
laboratories focused more on clinical follow up and less on
basic research.
Stage III (1982e2001)
In 1985, CORS was founded, which marked a new era in
Chinese orthopaedic research. During this period, ortho-
paedic research in China began to gain special emphasis
and some well-known national hospitals had set up labo-
ratories for basic orthopaedic research. Although CORS was
in its initiation stage with limited impact and inadequate
professional experience, it put great effort into organising
activities, such as combined academic activities with other
influential orthopaedic societies.
Stage IV (2002e2006)
With the development of CORS, it held the Sixth National
Orthopaedic Research Conference in 2003 in Shanghai
(China) independently (the previous 5 conferences were
jointly organized by COA and CORS). Since then, many ac-
ademic meetings and educational events have been held
every year, which greatly contributed to the progress of
orthopaedic research in China. At the same time, almost
every major hospital and medical college had its ownorthopaedic research laboratory or institute. Furthermore,
an increasing number of orthopaedic surgeons realised the
significance of and committed to orthopaedic research.
Subsequently, the number of professional staff in ortho-
paedic laboratories grew rapidly. However, the weaknesses
of CORS at this stage were obvious, such as the basic
research teams could only conduct advanced research
projects at a limited or less comparative level. In addition,
there were no clear and distinct research directions and the
awareness of transitional medicine and its related research
system needed awakening.
Stage V (2006epresent)
Orthopaedic research in China began to move into high
gear. In 2006, the society formally announced its English
name as the Chinese Orthopaedic Research Society and
became a member of the COA (Figure 1). The large number
of participants from home and abroad made the CORS
annual meeting an influential academic event in the med-
ical field (Figure 2). The increasing collaboration with
leading orthopaedic research groups has enabled Chinese
orthopaedic research to keep abreast of the international
trends in orthopaedic development. Nowadays, there are
over 30 orthopaedic research institutes in China, with a
total of 2000 professional research staff. In addition, there
are more than 3000 postgraduate students enrolled every
year, who focus on different research directions based on
their own expertise and interests. Encouragingly, there
have been significant achievements made in research on
peripheral nerve regeneration, bone graft implantation,
spinal degeneration diseases, musculoskeletal ageing, stem
cell and tissue engineering, scoliosis, trauma, sports med-
icine, three-dimensional printing, orthopaedic implants
and devices, and traditional Chinese medicine for
orthopaedics.
Current research focuses of orthopaedic basic
research in China
Although there are numerous directions of orthopaedic
basic research in China, data based on the National Nat-
ural Science Foundation of China (NSFC) have revealed
that there are two major aspects, ageing and the
musculoskeletal system, and musculoskeletal tissue
regeneration, which gained the largest (approximately 20-
fold) growth in funded projects and have made compelling
achievements.
Ageing and the musculoskeletal system
The ageing population is increasing rapidly and has become
a major socioeconomic and health burden worldwide. When
it comes to orthopaedics, there appears to be a close cor-
relation between ageing and musculoskeletal diseases.
Osteoporosis, intervertebral disc degeneration, and
degenerative osteoarthritis represent the highest incidence
among the age-related diseases. In recent years, we have
focused on the study of stem cell therapy for osteoporosis,
differentiation of bone-related cells, targeted treatment of
Figure 1 The English name of the Chinese Orthopaedic Research Society (CORS) was approved in 2006 and officially used at the
2007 annual meeting at the combined meeting with the Chinese Orthopaedic Association (COA).
Figure 2 Group photograph of council members of the Chinese Orthopaedic Research Society at the 2014 annual meeting.
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osteoblasts and osteoclasts, and large-scale clinical inves-
tigation of postmenopausal women with osteoporosis, and
believe that the scientific and technical breakthroughs
have great potential for the prevention, diagnosis, and
treatment of osteoporosis.
Although China has a long history in treating degenera-
tive osteoarthritis, Chinese basic researchers have only
worked on its pathogenesis in recent years. We have
focused on finding the key factors in osteoarthritis from
genetics to bone microenvironment, and have made some
encouraging progress.
Intervertebral disc degeneration accounts for most spi-
nal degenerative diseases pathologically, but its mechanism
remains unclear, which make the diagnosis and treatment
of spinal degenerative diseases difficult. The current belief
is that it is a multi-mechanism medical problem. At pre-
sent, several research institutes in China are investigating
the mechanism of inflammation, immunology, and stem cell
senescence, and propose potential medical solutions forprevention and treatment. Their findings have drawn
attention from peers worldwide.Musculoskeletal tissue regeneration
Regenerative medicine is a new branch of medicine,
dealing with the process of replacing, engineering, or
regenerating human tissues and/or organs to restore func-
tions. Regenerative medicine involves the engineering of
damaged tissues and organs via stimulating the patient’s
own repair mechanisms to heal previously irreparable tis-
sues or organs. In China, the related, stimulating pioneer
work originated from the subspecialty of limb trans-
plantation. Within a short period of development in or-
thopaedics, regenerative medicine has flourished in the
fields of internal fixation material, engineering bone sub-
stitutes, and stem cell therapy. The promising prospect of
musculoskeletal tissue regeneration attracts many ortho-
paedic basic/clinic researchers and engineers in China to
26 Z. Luo et al.focus research on materials for tissue engineering, regen-
eration cytokines, stem cells, and bone engineering. In
particular, it is worth mentioning that the study and
application of digital orthopaedics is gaining popularity and
has become a key motivation for research. Digital ortho-
paedic technology is a combination of digital information
technology and clinical orthopaedics. The achievements of
finite element analysis, rapid prototyping, three-
dimensional printing, CAD/CAM (computer-aided design/
computer-aided making), computer-assisted navigation,
and robot-assisted surgery, have made orthopaedic clinical
practice more precise, personal, and intuitional.Strengths and weaknesses of Chinese
orthopaedic basic research
Analysis of the strengths and weaknesses of orthopaedic
basic research in China may provide a reference for our
future development. As part of a SWOT (strengths, weak-
nesses, opportunities, and threats) analysis, we recognise
that rapid national economic growth has brought great
opportunities, but which are accompanied by threats that
we must overcome.
Strengths
The integration of basic research units into clinical ortho-
paedic departments is one of the unique aspects of ortho-
paedic research in China. It facilitates the direct
communication and collaboration between basic scientists
and surgeons, and allows them to plan research projects
jointly and apply the results to health care, known as the
bench-to-bedside and bedside-to-bench-to-bedside model
[3,4]. Another asset is that due to the huge population in
China, there is a large quantity of clinical data for clinical
research after proof-of-concept preclinical studies have
been performed.
Weaknesses
Most basic science research follows the international trend,
and there is a lack of innovative projects and world-leading
research teams.
The Chinese orthopaedic industry lags far behind the
United States (US) and other developed countries in
research and development (R&D) of medical products for
orthopaedic applications. For example, there is no domes-
tically made, high-quality artificial joint on the Chinese
market. A similar situation occurs in relation to spine and
trauma products. These facts reveal that there is a low
level of translational medicine in China, which along with
the inadequate number of technicians and designers,
limited level of mechanical processing and biological ma-
terials, and lack of clinical implant evaluation centres, in-
dicates that there is a long way to go before Chinese basic
science researchers can keep abreast of the international
cutting-edge advances.The large amount of data have not been fully and effi-
ciently used due to a lack of multicentre clinical research
teams.
The ability to identify weaknesses is important in order
to work out solutions step by step to effectively promote
translational research. Scholars and industrial sectors in
China are now making great efforts to counteract the
“valley of death”, which includes: (1) organising the mile-
stone eventdAnnual Congress of Orthopaedic Translational
Research in Shanghai (Shanghai OTR); and (2) the read-
justment of large national research programmes managed
by the Ministry of Sciences and Technology (MOST),
partially towards translational programmes. This is re-
flected in China’s 13th Five-Year Plan with a new initiation
in joint R&D grant applications to promote and enhance
collaborations among industries, universities and research
institutions, venture capitals, regulatory bodies, markets,
or end users [5,6].Opportunities
We are currently at a good time to develop and enhance
orthopaedic research. Opportunities include: (1) rapid
growth of the national economy and, accordingly, a rapid
increase in funding opportunities for research; (2)
increasing number of returnees after receiving education
and research training in leading countries for orthopaedic
and related research; they have become a significant
force or leaders in orthopaedic research and education in
China; (3) significant enhancement of local, national and
international collaborations as a result of the above two
key elements; and (4) stronger leadership in the CORS
community over the past 2 decades.Threats
The rapid increase in research funding creates distraction
and/or imbalance in energy distribution for conducting
research and spending time on frequent grant proposal
preparation at various levels. When threats refer to
external factors in industrial sectors, both preclinical and
clinical researchers are under great pressure to secure
funding for internal performance assessments. The threats
we are currently facing may include: (1) less time to
concentrate our energy on clinical and laboratory work; (2)
a lack of strategic funding support for promoting trans-
lational research and staff development, especially in
teaching and research hospitals where translational medi-
cine is the focus of R&D; (3) too much commitment to
academic meetings organised by various academic soci-
eties, research institutions or units, and teaching hospi-
talsdthis is particularly true for leading academic
institutions in orthopaedic research; and (4) regulatory is-
sues for R&D of medical devices and drugs that most re-
searchers are not familiar with. This is also known as a
significant difference between scientific publications and
regulatory bodies.
Chinese ORS and translational research 27Future of Chinese orthopaedic basic scientific
research
With the emphasis on the importance of basic medical
research and translational medicine in China’s 13th Five-
Year Plan, CORS is actively playing its role and draws the
blueprint for the national orthopaedic basic research plan
[5,6].
CORS supports collaborations between/among prepon-
derant research teams, so that they can take advantage of
each other’s strengths to make breakthroughs in their
related fields and expand their influence within the
discipline.
International exchange will be promoted. The bidding
for the 2016 International Combined Meeting of Orthopae-
dic Research Societies has been approved by the Interna-
tional Combined Orthopaedic Research Societies (ICORS)
and will take place in Xian (China) in September 2016 [7,8].
The meeting aims at stimulating orthopaedic and muscu-
loskeletal research in fields of biomedical engineering,
biology, chemistry, and veterinary and human clinical
research. The world-leading professionals will gather
together to share their latest advances and discuss topics
including results on clinical trials and the current trends of
orthopaedic research, which may have the potential to
change the current clinical practice.
The strategic partnership between CORS and Interna-
tional Chinese Musculoskeletal Research Society (ICMRS)
will be deepened. ICMRS is a nonprofit professional orga-
nization composed of scientists of Chinese heritage and
other international scholars in the field of musculoskeletal
research and its related areas [9]. ICMRS has set up a China
Development Committee, which is in charge of the coop-
eration between Mainland China, Hong Kong, Macau, and
Taiwan. Currently, there are 18 combined research centres
and several meetings or academic events have been held
that have yielded fruits.Figure 3 Group photograph of members of the International Co
current President of CORS, as the CORS delegation leader in ORS 20
Society.The connection with the other societies of the COA will
be strengthened [10]. By adopting the model of the Annual
Meeting of American Association of Orthopaedic Surgeons
(AAOS)/Orthopaedic Research Society (ORS) in the US
[11e13], the annual meeting of CORS opens 1 day before
the COA annual meeting and closes on the same day, which
strives to facilitate the exchange of ideas and promote
collaboration among scientists and clinicians [14]. There
will be more emphasis on translational research, as this is a
global trend as listed in the ORS 2020 [15e17] and our ul-
timate goal of orthopaedic research [3,4,11,18]. CORS has
been invited as the Guest Nation of 2017 ORS in San Diego,
CA, USA (Figure 3).
In order to enhance the function of CORS, similar to the
ORS, the Society will start to form several functionalised
committees to realise its mission and vision, including: (1)
membership committee for promoting orthopaedic
research; (2) preclinical and clinical research committee
for enhancing collaborative research; (3) education com-
mittee for establishing systemic basic and clinical research
training programmes; (4) industry engagement committee
for enhancing translational research and medical device,
implant, and drug development; (5) nominating a commit-
tee for identifying motivated and talented younger re-
searchers to engage in long-term sustainable development
of CORS; (6) international committee for liaising with in-
ternational sister societies for collaboration; and last but
not least (7) if feasible, a financial committee within the
COA, similar to the relationship between the ORS and AAOS.
CORS and translational medicine
The initial intentions of translationalmedicine are to shorten
the process from basic research to clinical applications and
promote the use of new technologies, drugs, and therapies
for patients. There are more basic orthopaedic researchers
who have begun to realise the significance and importance ofmbined Orthopaedic Research Societies with Professor Lu, the
16 (Orlando, FL, USA). CORS Z Chinese Orthopaedic Research
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themselves to the cause [2,4,14]. Although translational
medicine is an emphasis in China, it is still at the initial stage
and more awareness should be raised among Chinese re-
searchers. For example, the artificial cervical disc has been
widely used in Chinese hospitals since it was first imported in
2002. However, there is still no domestically made counter-
part at present, which can be attributed to the limited
capability of basic research. In fact, the first artificial cer-
vical disc was developed by Chinese scientists in 1984, but it
was never put into practice for 25 years. Fortunately, with
the establishment of key national translational medicine
centres, translational research has speeded up in China. It is
encouraging that CORS has recognised translational research
as its main focus in the new blueprint, although there are
many obstacles to overcome [14].
Current status of orthopaedic translational
research in China
The introduction of orthopaedic translational medicine in
China was relatively late, but its development has been
rapid [2,4,14]. In the National 12th Five-Year Plan for Sci-
ence and Technology Development, translational medicine
was adopted as a major strategy in the medical field in
China. In the past 5 years, more than 50 translational
medicine institutions have been established in China,
covering stem cells, regenerative medicine, drug develop-
ment, the musculoskeletal system, and most key medical
disciplines [4,17]. The investment from the government and
business companies is increasing precipitously. Every year,
academic conferences on orthopaedic translational medi-
cine are being held in most big cities. The most striking
meeting is the International Congress on Orthopaedic
Advanced Techniques and Clinical Translational Research
sponsored by an academician, Professor Kerong Dai, which
has been held consecutively for 10 years in Shanghai. This
meeting has had a profound influence on pushing trans-
lational medicine forward in China. Professor Dai is one of
the pioneers of orthopaedic translational research in China,
whose monograph, Translational MedicinedConcept,
Strategy and Practice, is acclaimed as a major reference in
translational research [19]. However, there are difficulties
in setting up an efficient operating system for a new branch
of medicine that is of pressing need. This requires collab-
oration among many disciplines and administrative offices.
Recruiting and cultivating talent takes time. In addition,
habits such as research mode and evaluation criteria need
further improvement.
Journal of Orthopaedic Translation
The Journal of Orthopaedic Translation (JOT) commenced
its publication in 2013 [20,21]. It is the first and only journal
that is dedicated to the field of orthopaedic translational
research. JOT covers topics including biotechnology, bio-
materials, bioengineering, disease-specific biomarkers, cell
and molecular biology, genomics, bioinformatics, immuno-
cytochemistry, molecular imaging, new drug development,
regulation/policy making, and any musculoskeletal related
translational research. The launch of JOT is a monumentalstep in the advancement of musculoskeletal care by
bringing cutting edge knowledge to the forefront and
allowing pioneers of orthopaedic translation to exchange
and mutually enhance expertise. CORS has established a
partnership with its holder, the Chinese Speaking Ortho-
paedic Society (CSOS) [22] and the ICMRS [9], and appeals
to CORS members to submit high-quality manuscripts.
Conclusion
China has a long history of orthopaedic research, docu-
mented in the history of traditional Chinese medicine for
musculoskeletal injuries and repair. Exchange and coopera-
tion with developing countries stimulate the development of
basic research and its translation. With the involvement of
more clinical experts and scientists after their study and/or
training abroad, Chinese orthopaedic research has made
remarkable achievements in recent years. Patient- and
clinic-oriented orthopaedic translational medicine is the
future focus of Chineseorthopaedic basic research. Themain
aim of this review is to demonstrate that Chinese orthopae-
dic researchhas abright future, if the recommendedchanges
outlined above are addressed.
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